Product Name

  • Name

    N-succinimidyl propionate

  • EINECS
  • CAS No. 30364-55-7
  • Article Data10
  • CAS DataBase
  • Density 1.31 g/cm3
  • Solubility
  • Melting Point 44～49℃
  • Formula C7H9NO4
  • Boiling Point 254.3 °C at 760 mmHg
  • Molecular Weight 171.153
  • Flash Point 107.6 °C
  • Transport Information
  • Appearance
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 30364-55-7 (N-succinimidyl propionate)
  • Hazard Symbols
  • Synonyms Succinimide,N-(propionyloxy)- (8CI);N-(Propionyloxy)succinimide;N-Succinimidyl propionate;1-(Propionyloxy)pyrrolidine-2,5-dione;
  • PSA 63.68000
  • LogP -0.05850

Synthetic route

1-hydroxy-pyrrolidine-2,5-dione
6066-82-6

1-hydroxy-pyrrolidine-2,5-dione

propionic acid
802294-64-0

propionic acid

succinimidyl propionate
30364-55-7

succinimidyl propionate

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In tetrahydrofuran at -78 - 20℃; for 3h;77%
With dicyclohexyl-carbodiimide In 1,4-dioxane74%
With dicyclohexyl-carbodiimide In tetrahydrofuran at 20℃; Cooling with ice;60%
With dicyclohexyl-carbodiimide In tetrahydrofuran20%
With dicyclohexyl-carbodiimide In ethyl acetate at 20℃;
1-hydroxy-pyrrolidine-2,5-dione
6066-82-6

1-hydroxy-pyrrolidine-2,5-dione

propionyl chloride
79-03-8

propionyl chloride

succinimidyl propionate
30364-55-7

succinimidyl propionate

Conditions
ConditionsYield
Stage #1: propionyl chloride With triethylamine In tetrahydrofuran
Stage #2: 1-hydroxy-pyrrolidine-2,5-dione In tetrahydrofuran at 20℃;		65%
With triethylamine In chloroform at 0 - 20℃; for 1.16667h;64%
With triethylamine In dichloromethane at 20℃; Cooling with ice;50%
1-hydroxy-pyrrolidine-2,5-dione
6066-82-6

1-hydroxy-pyrrolidine-2,5-dione

propionic acid anhydride
123-62-6

propionic acid anhydride

succinimidyl propionate
30364-55-7

succinimidyl propionate

Conditions
ConditionsYield
With hydrogenchloride20%
(R,R)-N,N-bis[N-(N-{8-[4-diphenylacetylamino-4-(4-hydroxybenzylaminocarbonyl)butyl]amino-(amino)methyleneamino-carbonylamino-3,6-dioxaoctyl}-4-aminocarbonylbenzoyl)-2-aminoethyl]ethane-1,2-diamine tetra(hydrotrifluoroacetate)

(R,R)-N,N-bis[N-(N-{8-[4-diphenylacetylamino-4-(4-hydroxybenzylaminocarbonyl)butyl]amino-(amino)methyleneamino-carbonylamino-3,6-dioxaoctyl}-4-aminocarbonylbenzoyl)-2-aminoethyl]ethane-1,2-diamine tetra(hydrotrifluoroacetate)

succinimidyl propionate
30364-55-7

succinimidyl propionate

trifluoroacetic acid
76-05-1

trifluoroacetic acid

3C2HF3O2*C93H116N18O17

3C2HF3O2*C93H116N18O17

Conditions
ConditionsYield
Stage #1: (R,R)-N,N-bis[N-(N-{8-[4-diphenylacetylamino-4-(4-hydroxybenzylaminocarbonyl)butyl]amino-(amino)methyleneamino-carbonylamino-3,6-dioxaoctyl}-4-aminocarbonylbenzoyl)-2-aminoethyl]ethane-1,2-diamine tetra(hydrotrifluoroacetate); succinimidyl propionate With triethylamine In N,N-dimethyl-formamide at 60℃; for 0.333333h; Microwave irradiation;
Stage #2: trifluoroacetic acid With water In N,N-dimethyl-formamide		98%
...Expand
5-(aminomethyl)-N1,N3-bis(2-(3-(1-(4-(1-(2-oxo-2-(11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-5-yl)ethyl)piperidin-4-yl)butyl)-1H-imidazol-4-yl)propanamido)ethyl)isophthalamide pentakis(hydrotrifluoroacetate)

5-(aminomethyl)-N1,N3-bis(2-(3-(1-(4-(1-(2-oxo-2-(11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-5-yl)ethyl)piperidin-4-yl)butyl)-1H-imidazol-4-yl)propanamido)ethyl)isophthalamide pentakis(hydrotrifluoroacetate)

succinimidyl propionate
30364-55-7

succinimidyl propionate

trifluoroacetic acid
76-05-1

trifluoroacetic acid

N1,N3-bis(2-(3-(1-(4-(1-(2-oxo-2-(11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-5-yl)ethyl)piperidin-4-yl)butyl)-1H-imidazol-4-yl)propanamido)ethyl)-5-(propionamidomethyl)isophthalamide tetrakis(hydrotrifluoroacetate)

N1,N3-bis(2-(3-(1-(4-(1-(2-oxo-2-(11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-5-yl)ethyl)piperidin-4-yl)butyl)-1H-imidazol-4-yl)propanamido)ethyl)-5-(propionamidomethyl)isophthalamide tetrakis(hydrotrifluoroacetate)

Conditions
ConditionsYield
Stage #1: 5-(aminomethyl)-N1,N3-bis(2-(3-(1-(4-(1-(2-oxo-2-(11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-5-yl)ethyl)piperidin-4-yl)butyl)-1H-imidazol-4-yl)propanamido)ethyl)isophthalamide pentakis(hydrotrifluoroacetate); succinimidyl propionate With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃;
Stage #2: trifluoroacetic acid In water; N,N-dimethyl-formamide		95%
...Expand
succinimidyl propionate
30364-55-7

succinimidyl propionate

C43H75N5O28

C43H75N5O28

C46H81N3O29

C46H81N3O29

Conditions
ConditionsYield
With 4-methyl-morpholine In methanol90%
H-Arg-{Nω-[N-(8-amino-3,6-dioxaoctyl)aminocarbonyl]}Arg-Pro-Tyr-Ile-Leu-OH tetrakis(hydrotrifluoroacetate)

H-Arg-{Nω-[N-(8-amino-3,6-dioxaoctyl)aminocarbonyl]}Arg-Pro-Tyr-Ile-Leu-OH tetrakis(hydrotrifluoroacetate)

succinimidyl propionate
30364-55-7

succinimidyl propionate

trifluoroacetic acid
76-05-1

trifluoroacetic acid

H-Arg-{Nω-[N-(8-propanoylamino-3,6-dioxaoctyl)-aminocarbonyl]}Arg-Pro-Tyr-Ile-Leu-OH tris(hydrotrifluoroacetate)

H-Arg-{Nω-[N-(8-propanoylamino-3,6-dioxaoctyl)-aminocarbonyl]}Arg-Pro-Tyr-Ile-Leu-OH tris(hydrotrifluoroacetate)

Conditions
ConditionsYield
Stage #1: H-Arg-{Nω-[N-(8-amino-3,6-dioxaoctyl)aminocarbonyl]}Arg-Pro-Tyr-Ile-Leu-OH tetrakis(hydrotrifluoroacetate); succinimidyl propionate With potassium hydrogencarbonate; N-ethyl-N,N-diisopropylamine In water; N,N-dimethyl-formamide at 20℃; for 1.25h;
Stage #2: trifluoroacetic acid In water; N,N-dimethyl-formamide		89%
...Expand
5-((4-(4-(2-(2-aminoethylcarbamoyl)guanidin-1-yl)butyl)piperidin-1-yl)acetyl)-5H-dibenzo[b,e][1,4]diazepin-11(10H)-one tris(hydrotrifluoroacetate)

5-((4-(4-(2-(2-aminoethylcarbamoyl)guanidin-1-yl)butyl)piperidin-1-yl)acetyl)-5H-dibenzo[b,e][1,4]diazepin-11(10H)-one tris(hydrotrifluoroacetate)

succinimidyl propionate
30364-55-7

succinimidyl propionate

5-((4-(4-(2-(2-propionamidoethylcarbamoyl)guanidin-1-yl)butyl)piperidin-1-yl)acetyl)-5H-dibenzo[b,e][1,4]diazepin-11(10H)-one

5-((4-(4-(2-(2-propionamidoethylcarbamoyl)guanidin-1-yl)butyl)piperidin-1-yl)acetyl)-5H-dibenzo[b,e][1,4]diazepin-11(10H)-one

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide; acetonitrile at 20℃; for 0.75h;87%
H-Asp-{Nω-[N-(8-amino-3,6-dioxaoctyl)aminocarbonyl]}Arg-Val-Tyr-Ile-His-Pro-Phe-OH tetrakis(hydrotrifluoroacetate)

H-Asp-{Nω-[N-(8-amino-3,6-dioxaoctyl)aminocarbonyl]}Arg-Val-Tyr-Ile-His-Pro-Phe-OH tetrakis(hydrotrifluoroacetate)

succinimidyl propionate
30364-55-7

succinimidyl propionate

trifluoroacetic acid
76-05-1

trifluoroacetic acid

H-Asp-{Nω-[N-(8-propanoylamino-3,6-dioxaoctyl)aminocarbonyl]}-Arg-Val-Tyr-Ile-His-Pro-Phe-OH tris(hydrotrifluoroacetate)

H-Asp-{Nω-[N-(8-propanoylamino-3,6-dioxaoctyl)aminocarbonyl]}-Arg-Val-Tyr-Ile-His-Pro-Phe-OH tris(hydrotrifluoroacetate)

Conditions
ConditionsYield
Stage #1: H-Asp-{Nω-[N-(8-amino-3,6-dioxaoctyl)aminocarbonyl]}Arg-Val-Tyr-Ile-His-Pro-Phe-OH tetrakis(hydrotrifluoroacetate); succinimidyl propionate With potassium hydrogencarbonate; N-ethyl-N,N-diisopropylamine In water; N,N-dimethyl-formamide at 20℃; for 1.25h;
Stage #2: trifluoroacetic acid In water; N,N-dimethyl-formamide		87%
...Expand
succinimidyl propionate
30364-55-7

succinimidyl propionate

Sphingosine-1-phosphate
26993-30-6

Sphingosine-1-phosphate

N-[(1S,2R,3E)-2-hydroxy-1-[(phosphonooxy)methyl]-3-heptadecen-1-yl]-propanamide
1093733-23-3

N-[(1S,2R,3E)-2-hydroxy-1-[(phosphonooxy)methyl]-3-heptadecen-1-yl]-propanamide

Conditions
ConditionsYield
Stage #1: Sphingosine-1-phosphate With N,O-bis-(trimethylsilyl)-acetamide at 20℃;
Stage #2: succinimidyl propionate With dmap; N-ethyl-N,N-diisopropylamine In dichloromethane at 0 - 20℃; Further stages.;		86%
3-((6-aminohexyl)amino)-4-((3-(3-(piperidin-1-ylmethyl)phenoxy)propyl)amino)cyclobut-3-ene-1,2-dione bis(hydrotrifluoracetate)

3-((6-aminohexyl)amino)-4-((3-(3-(piperidin-1-ylmethyl)phenoxy)propyl)amino)cyclobut-3-ene-1,2-dione bis(hydrotrifluoracetate)

succinimidyl propionate
30364-55-7

succinimidyl propionate

N-[6-(3,4-dioxo-2-(3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino)cyclobut-1-enylamino)hexyl]propionamide hydrotrifluoroacetate

N-[6-(3,4-dioxo-2-(3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino)cyclobut-1-enylamino)hexyl]propionamide hydrotrifluoroacetate

Conditions
ConditionsYield
Stage #1: 3-((6-aminohexyl)amino)-4-((3-(3-(piperidin-1-ylmethyl)phenoxy)propyl)amino)cyclobut-3-ene-1,2-dione bis(hydrotrifluoracetate) With triethylamine In dichloromethane for 0.0833333h;
Stage #2: succinimidyl propionate at 20℃; for 16h;		86%
H-{Nω-[N-(4-aminobutyl)aminocarbonyl]}Arg-Arg-Pro-Tyr-Ile-Leu-OH tetrakis(hydrotrifluoroacetate)

H-{Nω-[N-(4-aminobutyl)aminocarbonyl]}Arg-Arg-Pro-Tyr-Ile-Leu-OH tetrakis(hydrotrifluoroacetate)

succinimidyl propionate
30364-55-7

succinimidyl propionate

trifluoroacetic acid
76-05-1

trifluoroacetic acid

H-{Nω-[N-(4-propanoylaminobutyl)aminocarbonyl]}Arg-Arg-Pro-Tyr-Ile-Leu-OH tris(hydrotrifluoroacetate)

H-{Nω-[N-(4-propanoylaminobutyl)aminocarbonyl]}Arg-Arg-Pro-Tyr-Ile-Leu-OH tris(hydrotrifluoroacetate)

Conditions
ConditionsYield
Stage #1: H-{Nω-[N-(4-aminobutyl)aminocarbonyl]}Arg-Arg-Pro-Tyr-Ile-Leu-OH tetrakis(hydrotrifluoroacetate); succinimidyl propionate With potassium hydrogencarbonate; N-ethyl-N,N-diisopropylamine In water; N,N-dimethyl-formamide at 20℃; for 1.25h;
Stage #2: trifluoroacetic acid In water; N,N-dimethyl-formamide		86%
...Expand
H-{Nω-[N-(8-amino-3,6-dioxaoctyl)aminocarbonyl]}Arg-Arg-Pro-Tyr-Ile-Leu-OH tetrakis(hydrotrifluoroacetate)

H-{Nω-[N-(8-amino-3,6-dioxaoctyl)aminocarbonyl]}Arg-Arg-Pro-Tyr-Ile-Leu-OH tetrakis(hydrotrifluoroacetate)

succinimidyl propionate
30364-55-7

succinimidyl propionate

trifluoroacetic acid
76-05-1

trifluoroacetic acid

H-{Nω-[N-(8-propanoylamino-3,6-dioxaoctyl)aminocarbonyl]}-Arg-Arg-Pro-Tyr-Ile-Leu-OH tris(hydrotrifluoroacetate)

H-{Nω-[N-(8-propanoylamino-3,6-dioxaoctyl)aminocarbonyl]}-Arg-Arg-Pro-Tyr-Ile-Leu-OH tris(hydrotrifluoroacetate)

Conditions
ConditionsYield
Stage #1: H-{Nω-[N-(8-amino-3,6-dioxaoctyl)aminocarbonyl]}Arg-Arg-Pro-Tyr-Ile-Leu-OH tetrakis(hydrotrifluoroacetate); succinimidyl propionate With potassium hydrogencarbonate; N-ethyl-N,N-diisopropylamine In water; N,N-dimethyl-formamide at 20℃; for 1.25h;
Stage #2: trifluoroacetic acid In water; N,N-dimethyl-formamide		86%
...Expand
(R)-Nω-(2-aminoethyl)aminocarbonyl-Nα-diphenylacetyl-(4-hydroxybenzyl)argininamide bis(hydrotrifluoroacetate)

(R)-Nω-(2-aminoethyl)aminocarbonyl-Nα-diphenylacetyl-(4-hydroxybenzyl)argininamide bis(hydrotrifluoroacetate)

succinimidyl propionate
30364-55-7

succinimidyl propionate

(R)-Nα-diphenylacetyl-Nω-(propionylaminoethyl)aminocarbonyl-(4-hydroxybenzyl)argininamide hydrotrifluoroacetate

(R)-Nα-diphenylacetyl-Nω-(propionylaminoethyl)aminocarbonyl-(4-hydroxybenzyl)argininamide hydrotrifluoroacetate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 1.5h;83%
H-Glu-Tyr-Trp-Ser-Leu-Ala-Ala-Pro-Gln-{Nω-[N-(4-aminobutyl)-aminocarbonyl]}Arg-Phe-NH2 tris(hydrotrifluoroacetate)

H-Glu-Tyr-Trp-Ser-Leu-Ala-Ala-Pro-Gln-{Nω-[N-(4-aminobutyl)-aminocarbonyl]}Arg-Phe-NH2 tris(hydrotrifluoroacetate)

succinimidyl propionate
30364-55-7

succinimidyl propionate

C88H136N26O18*4C2HF3O2

C88H136N26O18*4C2HF3O2

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃;83%
2-amino-2-deoxy-D-glucopyranose-1-(dihydrogen phosphate)
2152-75-2

2-amino-2-deoxy-D-glucopyranose-1-(dihydrogen phosphate)

succinimidyl propionate
30364-55-7

succinimidyl propionate

2-deoxy-2-propionylamido-α-D-glucopyranosyl phosphate

2-deoxy-2-propionylamido-α-D-glucopyranosyl phosphate

Conditions
ConditionsYield
With potassium hydroxide In tetrahydrofuran; water at 20℃; pH=7.0;79%
H-Asp-{Nω-[N-(4-aminobutyl)aminocarbonyl]}Arg-Val-Tyr-Ile-His-Pro-Phe-OH tetrakis(hydrotrifluoroacetate)

H-Asp-{Nω-[N-(4-aminobutyl)aminocarbonyl]}Arg-Val-Tyr-Ile-His-Pro-Phe-OH tetrakis(hydrotrifluoroacetate)

succinimidyl propionate
30364-55-7

succinimidyl propionate

trifluoroacetic acid
76-05-1

trifluoroacetic acid

H-Asp-{Nω-[N-(4-propanoylaminobutyl)aminocarbonyl]}Arg-Val-Tyr-Ile-His-Pro-Phe-OH tris(hydrotrifluoroacetate)

H-Asp-{Nω-[N-(4-propanoylaminobutyl)aminocarbonyl]}Arg-Val-Tyr-Ile-His-Pro-Phe-OH tris(hydrotrifluoroacetate)

Conditions
ConditionsYield
Stage #1: H-Asp-{Nω-[N-(4-aminobutyl)aminocarbonyl]}Arg-Val-Tyr-Ile-His-Pro-Phe-OH tetrakis(hydrotrifluoroacetate); succinimidyl propionate With potassium hydrogencarbonate; N-ethyl-N,N-diisopropylamine In water; N,N-dimethyl-formamide at 20℃; for 1.25h;
Stage #2: trifluoroacetic acid In water; N,N-dimethyl-formamide		77%
...Expand
[(15)N2]-mono(boc)-S-methylisothiourea
1185762-92-8

[(15)N2]-mono(boc)-S-methylisothiourea

succinimidyl propionate
30364-55-7

succinimidyl propionate

[(15)N2]-N(boc)-N'(propionyl)-S-methylisothiourea
1185762-93-9

[(15)N2]-N(boc)-N'(propionyl)-S-methylisothiourea

Conditions
ConditionsYield
With dmap; triethylamine In dichloromethane at 20℃;76%
1-(amino{[3-(2-amino-4-methylthiazol-5-yl)propyl]amino}methylene)-3-(8-aminooctyl)urea trihydrotrifluoroacetate

1-(amino{[3-(2-amino-4-methylthiazol-5-yl)propyl]amino}methylene)-3-(8-aminooctyl)urea trihydrotrifluoroacetate

succinimidyl propionate
30364-55-7

succinimidyl propionate

N-{8-(amino{[3-(2-amino-4-methylthiazol-5-yl)propyl]amino}methylene)ureido-1-octyl}propionic amide dihydrotrifluoroacetate

N-{8-(amino{[3-(2-amino-4-methylthiazol-5-yl)propyl]amino}methylene)ureido-1-octyl}propionic amide dihydrotrifluoroacetate

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 20℃; for 2h;75%
5,5′-(2,2′-(((6-amino-1,4-diazepane-1,4-diyl)bis(butane-4,1-diyl))bis(piperidine-4,1-diyl))bis(acetyl))bis(5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one) pentakis(hydrotrifluoroacetate)

5,5′-(2,2′-(((6-amino-1,4-diazepane-1,4-diyl)bis(butane-4,1-diyl))bis(piperidine-4,1-diyl))bis(acetyl))bis(5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one) pentakis(hydrotrifluoroacetate)

succinimidyl propionate
30364-55-7

succinimidyl propionate

trifluoroacetic acid
76-05-1

trifluoroacetic acid

N-(1,4-bis(4-(1-(2-oxo-2-(11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-5-yl)ethyl)piperidin-4-yl)butyl)-1,4-diazepan-6-yl)propionamide tetrakis(hydrotrifluoroacetate)

N-(1,4-bis(4-(1-(2-oxo-2-(11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-5-yl)ethyl)piperidin-4-yl)butyl)-1,4-diazepan-6-yl)propionamide tetrakis(hydrotrifluoroacetate)

Conditions
ConditionsYield
Stage #1: 5,5′-(2,2′-(((6-amino-1,4-diazepane-1,4-diyl)bis(butane-4,1-diyl))bis(piperidine-4,1-diyl))bis(acetyl))bis(5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one) pentakis(hydrotrifluoroacetate); succinimidyl propionate With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃;
Stage #2: trifluoroacetic acid In water; N,N-dimethyl-formamide		72%
...Expand
(R)-Nα-diphenylacetyl-Nω-(aminopropyl)aminocarbonyl(4-hydroxybenzyl)argininamide bis(hydrotrifluoroacetate)

(R)-Nα-diphenylacetyl-Nω-(aminopropyl)aminocarbonyl(4-hydroxybenzyl)argininamide bis(hydrotrifluoroacetate)

succinimidyl propionate
30364-55-7

succinimidyl propionate

(R)-Nα-diphenylacetyl-Nω-(propionylaminopropyl)aminocarbonyl(4-hydroxybenzyl)argininamide hydrotrifluoroacetate

(R)-Nα-diphenylacetyl-Nω-(propionylaminopropyl)aminocarbonyl(4-hydroxybenzyl)argininamide hydrotrifluoroacetate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃;72%
5-((4-(3-(2-(2-aminoethylcarbamoyl)guanidin-1-yl)propyl)piperidin-1-yl)acetyl)-5H-dibenzo[b,e][1,4]diazepin-11(10H)-one tris(hydrotrifluoroacetate)

5-((4-(3-(2-(2-aminoethylcarbamoyl)guanidin-1-yl)propyl)piperidin-1-yl)acetyl)-5H-dibenzo[b,e][1,4]diazepin-11(10H)-one tris(hydrotrifluoroacetate)

succinimidyl propionate
30364-55-7

succinimidyl propionate

5-((4-(3-(2-(2-propionamidoethylcarbamoyl)guanidin-1-yl)propyl)piperidin-1-yl)acetyl)-5H-dibenzo[b,e][1,4]diazepin-11(10H)-one

5-((4-(3-(2-(2-propionamidoethylcarbamoyl)guanidin-1-yl)propyl)piperidin-1-yl)acetyl)-5H-dibenzo[b,e][1,4]diazepin-11(10H)-one

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 2.5h;70%
2-deoxy-2-amino glucose
90-76-6, 90-77-7, 530-23-4, 579-32-8, 579-33-9, 643-68-5, 2596-19-2, 6490-68-2, 6490-70-6, 6490-72-8, 6490-73-9, 6490-74-0, 14196-84-0, 14196-86-2, 14257-69-3, 58381-21-8

2-deoxy-2-amino glucose

succinimidyl propionate
30364-55-7

succinimidyl propionate

N-[(3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]propanamide
6857-21-2, 14215-79-3, 15475-14-6

N-[(3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]propanamide

Conditions
ConditionsYield
With triethylamine In methanol at 20℃; for 6h;70%
diacetyl-2-(4-N-methyl-3-thiosemicarbazone)-3-(4-N-amino-3-thiosemicarbazone)
918879-58-0

diacetyl-2-(4-N-methyl-3-thiosemicarbazone)-3-(4-N-amino-3-thiosemicarbazone)

succinimidyl propionate
30364-55-7

succinimidyl propionate

C10H19N7OS2
1208998-91-7

C10H19N7OS2

Conditions
ConditionsYield
With triethylamine In dimethyl sulfoxide for 6h;69%
3-((4-aminobutyl)amino)-4-((3-(3-(piperidin-1-ylmethyl)phenoxy)propyl)amino)cyclobut-3-ene-1,2-dione bis(hydrotrifluoracetate)

3-((4-aminobutyl)amino)-4-((3-(3-(piperidin-1-ylmethyl)phenoxy)propyl)amino)cyclobut-3-ene-1,2-dione bis(hydrotrifluoracetate)

succinimidyl propionate
30364-55-7

succinimidyl propionate

trifluoroacetic acid
76-05-1

trifluoroacetic acid

N-[4-(3,4-dioxo-2-{3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino}cyclobut-1-enylamino)butyl]propionamide hydrotrifluoroacetate

N-[4-(3,4-dioxo-2-{3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino}cyclobut-1-enylamino)butyl]propionamide hydrotrifluoroacetate

Conditions
ConditionsYield
Stage #1: 3-((4-aminobutyl)amino)-4-((3-(3-(piperidin-1-ylmethyl)phenoxy)propyl)amino)cyclobut-3-ene-1,2-dione bis(hydrotrifluoracetate); succinimidyl propionate With triethylamine In dimethyl sulfoxide at 20℃; for 0.75h;
Stage #2: trifluoroacetic acid In acetonitrile		69%
...Expand
N-aminoethylcyclopamine
334616-31-8

N-aminoethylcyclopamine

succinimidyl propionate
30364-55-7

succinimidyl propionate

N-(N'-propionylaminoethyl)cyclopamine

N-(N'-propionylaminoethyl)cyclopamine

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 12h;67%
(R)-Nα-diphenylacetyl-{4-[4-(2-aminoacetyl)aminobutylaminocarbonyl aminomethyl]benzyl}argininamide bis(hydrotrifluoroacetate)

(R)-Nα-diphenylacetyl-{4-[4-(2-aminoacetyl)aminobutylaminocarbonyl aminomethyl]benzyl}argininamide bis(hydrotrifluoroacetate)

succinimidyl propionate
30364-55-7

succinimidyl propionate

trifluoroacetic acid
76-05-1

trifluoroacetic acid

(R)-Nα-diphenylacetyl-{4-[4-(propionylaminomethylcarbonyl)aminobutylaminocarbonyl aminomethyl]benzyl}argininamide hydrotrifluoroacetate

(R)-Nα-diphenylacetyl-{4-[4-(propionylaminomethylcarbonyl)aminobutylaminocarbonyl aminomethyl]benzyl}argininamide hydrotrifluoroacetate

Conditions
ConditionsYield
Stage #1: (R)-Nα-diphenylacetyl-{4-[4-(2-aminoacetyl)aminobutylaminocarbonyl aminomethyl]benzyl}argininamide bis(hydrotrifluoroacetate); succinimidyl propionate With triethylamine In N,N-dimethyl-formamide at 20 - 50℃; for 2h;
Stage #2: trifluoroacetic acid With water In N,N-dimethyl-formamide		65%
...Expand
3-(5-aminopentylamino)-4-{3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino}cyclobut-3-ene-1,2-dione bis(hydrotrifluoroacetate)

3-(5-aminopentylamino)-4-{3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino}cyclobut-3-ene-1,2-dione bis(hydrotrifluoroacetate)

succinimidyl propionate
30364-55-7

succinimidyl propionate

trifluoroacetic acid
76-05-1

trifluoroacetic acid

N-[5-(3,4-dioxo-2-{3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino}cyclobut-1-enylamino)pentyl]propionamide hydrotrifluoroacetate

N-[5-(3,4-dioxo-2-{3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino}cyclobut-1-enylamino)pentyl]propionamide hydrotrifluoroacetate

Conditions
ConditionsYield
Stage #1: 3-(5-aminopentylamino)-4-{3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino}cyclobut-3-ene-1,2-dione bis(hydrotrifluoroacetate); succinimidyl propionate With triethylamine In methanol; dimethyl sulfoxide at 20℃; for 0.5h;
Stage #2: trifluoroacetic acid In acetonitrile		61%
...Expand

2,5-Pyrrolidinedione,1-(1-oxopropoxy)- Specification

The 2,5-Pyrrolidinedione,1-(1-oxopropoxy)-, with the CAS registry number 30364-55-7, is also known as N-(Propionyloxy)succinimide. This chemical's molecular formula is C7H9NO4 and molecular weight is 171.15. What's more, its systematic name is 1-(propanoyloxy)pyrrolidine-2,5-dione. 

Physical properties of 2,5-Pyrrolidinedione,1-(1-oxopropoxy)- are: (1)ACD/LogP: -1.28; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -1.27; (4)ACD/LogD (pH 7.4): -1.27; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 4.82; (8)ACD/KOC (pH 7.4): 4.82; (9)#H bond acceptors: 5; (10)#H bond donors: 0; (11)#Freely Rotating Bonds: 3; (12)Polar Surface Area: 63.68 Å2; (13)Index of Refraction: 1.501; (14)Molar Refractivity: 38.38 cm3; (15)Molar Volume: 130.2 cm3; (16)Polarizability: 15.21×10-24cm3; (17)Surface Tension: 48.1 dyne/cm; (18)Density: 1.31 g/cm3; (19)Flash Point: 107.6 °C; (20)Enthalpy of Vaporization: 49.18 kJ/mol; (21)Boiling Point: 254.3 °C at 760 mmHg; (22)Vapour Pressure: 0.0174 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES: O=C1N(OC(=O)CC)C(=O)CC1
(2)InChI: InChI=1S/C7H9NO4/c1-2-7(11)12-8-5(9)3-4-6(8)10/h2-4H2,1H3
(3)InChIKey: AASBXERNXVFUEJ-UHFFFAOYSA-N

Related Products

Hot Products

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View